{"id":"W2949315927","doi":"10.1097/01.hs9.0000563256.18006.bf","title":"PS1244 REAL‐WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) OF PATIENTS DIAGNOSED WITH CLASSICAL HODGKIN LYMPHOMA (CHL) TREATED WITH ANTI‐PD1 CHECKPOINT INHIBITORS IN THE UNITED STATES (US)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Pembrolizumab; Nivolumab; Pediatrics; Internal medicine; Retrospective cohort study; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001610629,0.0003548286,0.0006126816,0.0001837151,0.00007200085,0.00002763856,0.0001247901,0.0001282432,0.000100004],"category_scores_gemma":[0.00003162806,0.0001935904,0.0000866435,0.001456296,0.0001304213,0.0000864634,0.00003460504,0.0001289009,0.00002004048],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003646565,"about_ca_system_score_gemma":0.0001784872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006232785,"about_ca_topic_score_gemma":0.004097967,"domain_scores_codex":[0.9976879,0.0002184718,0.0005336039,0.0004833884,0.0006637358,0.0004128822],"domain_scores_gemma":[0.9984228,0.0002630563,0.0003029435,0.0006089635,0.000242772,0.0001594685],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001234521,0.002311295,0.9887163,0.0002616787,0.0001094488,0.0001574063,0.001322664,0.0001165169,0.00002056256,0.0001863183,0.001141186,0.004422126],"study_design_scores_gemma":[0.01309247,0.002709085,0.9681856,0.001246148,0.000144545,0.00001355488,0.002054139,0.0003988285,0.003487175,0.000008452409,0.008430016,0.000229977],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994825,0.0001760942,0.000002290468,0.001143461,0.00002528654,0.001686898,0.00004636877,0.00006798121,0.00202663],"genre_scores_gemma":[0.9972395,0.0002154312,0.0001142314,0.0006105087,0.00003664874,0.0001339659,0.001272242,0.00005910561,0.0003183237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02053066,"threshold_uncertainty_score":0.9422147,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01748511497946377,"score_gpt":0.2568747551991565,"score_spread":0.2393896402196928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}